Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus

Published:2020-07-17 Issue:29 Volume:99 Page:e21236
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Cho Eun-Hee,Han Kyungdo,Kim Bongseong,Lee Dae Ho

Funder

National Health Insurance Service

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference21 articles.

1. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study;Wei;Diabetes Care,1998

2. 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study;Hansen;BMC Public Health,2009

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

4. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

5. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes;Johnson;Diabetes Care,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity;Aging;2023-02-02

2. The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study;Aging;2022-11-17

3. Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity;2022-10-24

4. Increased Frequency of Severe Hypoglycemia with the Modified-Release Gliclazide Compared to Glimepiride in Diabetic Older Adults; Propensity Score-Adjusted Analysis;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-05

5. Association of history of metformin use with delirium and mortality: A retrospective cohort study;2022-04-03